Hussain A Ali Shabbir, Hafeez Abdul, Javed Ayesha, Akhtar Mahwish, Mallick Muhammad Jawaid
Oncology, Ziauddin University, Karachi, PAK.
Oncology, Karachi Institute of Radiotherapy and Nuclear Medicine (KIRAN) Hospital, Karachi, PAK.
Cureus. 2021 Jun 17;13(6):e15723. doi: 10.7759/cureus.15723. eCollection 2021 Jun.
Introduction Squamous cell carcinoma of the oral cavity is one of the top 10 malignancies reported globally. Pakistan has a high incidence of oral cancers due to the prevailing poor lifestyle habits/addictions of Pakistanis, and most patients with squamous cell carcinoma present with stage III or IV locally advanced disease. Recommended guidelines indicate surgery as the mainstay of treatment followed by radiotherapy (RT). The addition of induction chemotherapy before surgery or radiation therapy might improve outcomes with increased locoregional control rates. Methods This was a retrospective cohort study comparing the outcomes between surgery followed by concurrent chemoradiotherapy (CCRT) and induction chemotherapy followed by RT. This study primarily aimed to evaluate progression-free survival (PFS) and determine the toxicity of chemotherapy. Results We found out that the mean PFS among patients undergoing surgery and CCRT and those receiving induction chemotherapy followed by RT were 6.40 (± 2.38) months and 7.6 (± 4.76) months, respectively. Conclusion Induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil followed by RT shows satisfactory results with acceptable toxicity. However, the results are not statistically significant but support the already published data on this treatment aspect of oral cavity cancers.
引言 口腔鳞状细胞癌是全球报告的十大恶性肿瘤之一。由于巴基斯坦人普遍存在不良生活习惯/成瘾问题,巴基斯坦口腔癌发病率很高,大多数口腔鳞状细胞癌患者就诊时已处于III期或IV期局部晚期疾病。推荐指南指出,手术是主要治疗手段,放疗(RT)紧随其后。在手术或放疗前加用诱导化疗可能会提高局部区域控制率,从而改善治疗效果。方法 这是一项回顾性队列研究,比较了手术联合同步放化疗(CCRT)与诱导化疗后放疗的疗效。本研究主要目的是评估无进展生存期(PFS)并确定化疗的毒性。结果 我们发现,接受手术和CCRT的患者以及接受诱导化疗后放疗的患者的平均PFS分别为6.40(±2.38)个月和7.6(±4.76)个月。结论 多西他赛、顺铂和5-氟尿嘧啶诱导化疗后放疗显示出令人满意的结果,毒性可接受。然而,结果无统计学意义,但支持已发表的关于口腔癌这一治疗方面的数据。